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ABSTRACT
POINT OF CARE DIAGNOSTICS AND HEALTH MONITORING DEVICES
FEBRUARY 2016
AKSHAYA SHANMUGAM, B.E., ANNA UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS, AMHERST
Directed by: Professor Christopher D. Salthouse

Existing disease screening methods mostly rely on symptom based diagnosis. This is
mainly because of lack of accessibility and cost associated with the tests. Testing for the
presence of the disease after the onset of symptoms has a negative impact on chances of
survival and treatment costs.

Miniaturized low cost diagnostic devices that can be used outside the hospital setting
can provide continuous health monitoring and aid in early diagnosis. This thesis presents
techniques to develop such disease screening and health monitoring devices. The techniques
presented here focus on medical devices that can benefit from microfluidic devices,
fluorescence imaging, and antibody testing.
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CHAPTER 1
INTRODUCTION

Diseases have existed longer than humans; disease diagnosis can be dated back to 400
BC, when the oldest known diagnostic test was performed. The test involved pouring urine on the
ground and observing if it attracted insects. During the middle ages and the seventeenth century,
studying body fluids, mainly urine was the predominant technique for diagnosis. In 1754, clinical
diagnostics by measuring heart rate, blood pressure, and temperature was refined. By 1850,
stethoscopes, ophthalmoscopes, and laryngoscopes were used in clinical examination. The next
huge stride in diagnosis was the invention of microscopes, X-ray, chemical tests, and
bacteriological tests. Diagnostic techniques picked up in the mid-1800s with the invention of new
devices and establishment of hospital labs [1].

These days there are a plethora of clinically used diagnostic tools and tests. Diagnostic
tests can be broadly classified as belonging to biochemistry, hematology, microbiology, radiology,
and pathology. Specialized equipment and set-ups are currently used to perform these tests to
diagnose an array of diseases. At hospitals, tests are usually ordered to determine the cause of
illness after patients show symptoms. These tests range from minimally invasive tests such as
blood tests and physical examination, to more invasive procedures such as angiography and
biopsy [2] [3].

Proper diagnosis plays a defining role in medical costs associated with treatment and
effectiveness of the treatment. Although existing screening methods have worked well, diagnosis
is usually performed only after symptoms start to appear. Life threatening diseases such as
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cancer, HIV, hepatitis C, heart diseases, and stroke show very few or no symptoms in the early
stages. They are diagnosed by an observant eye during an annual general health checkup, or in
most cases undiagnosed till the health of the individual has been adversely affected. This
uncertainty has cost thousands of lives every year; heart diseases, cancer, and stroke are among
the top five causes of death contributing to about 1,302,200 deaths each year in the US [4]. These
diseases also pose a huge economic burden to the country; more than 75% of the health care
expenditure in the US is on people with chronic conditions [5].

Mobile health monitoring and hand held devices can solve this problem by providing
personalized care. The wide spread use of such technology has enabled the use of medical devices
outside hospitals and clinics. Devices with a wide range of complexity such as temperature
sensors, heart rate monitoring devices, calorie counters, sugar level monitor, blood pressure
monitor, and activity monitoring devices are commercially available today. The use of mobile
devices such as mobile phones, smart phones, and other mobile communication technologies in
the recent past has garnered huge interest and has led to the emergence of the field known as
mHealth [6] [7]. Some groups have also developed systems for monitoring various biological
signals to provide more information on an individual’s health [8]. The global market for medical
devices in 2013 was 348 billion dollars and has an average growth of 3% each year [9].

This thesis presents 3 key techniques: microfluidic fabrication for miniaturized sensors,
miniaturized fluorescence imaging system, and a point of care hepatitis C screening device.
Microfluidic devices aid in sample delivery and housing the sample under study in most
miniaturized devices. New microfluidic fabrication techniques are required for different
applications. The second chapter discusses the fabrication techniques for developing microfluidic
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devices directly on CMOS sensors. These devices can be used for optical examination of sample
or integrated with existing chemical sensors for disease screening, bio sensing, cytological studies,
and sample flow imaging to name a few.

The third chapter presents a lensless fluorescence imaging device capable of detecting
and quantifying the fluorescence signal of sample. The specificity of fluorescence imaging is
currently used in labs to diagnose many types of cancers, AIDS, and other blood related disorders.
This device can be employed in clinical application that require qualitative and quantitative data
from fluorescently stained sample.

The proof of concept for a novel hepatitis C screening device is presented in chapter four.
This device will be capable of detecting the antibody in blood, detecting the virus, and classifying
the virus subtype. The proposed device overcomes the drawbacks of conventional screening
devices and techniques. The functionality of the presented screening technique can also be
employed to screen other diseases and detect various biomolecules.

This thesis proposal presents a detailed literature review and results for each of these
projects. The aim of this work is to develop alternate techniques and methods that aid in the
advancement of health monitoring and disease screening. Applications for the techniques
presented in this thesis are numerous. Low cost technologies that can provide continuous health
monitoring, and portable screening devices will reform the healthcare industry in the US.
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CHAPTER 2
HEAT SENSITIVE ADHESIVE TAPE MICROFLUIDIC DEVICE ON CMOS

Microfluidic devices have played a critical role in miniaturization of numerous devices by
providing a means for sample delivery. Microfluidics perform complex tasks such as mixing,
focusing, and growing live cells on miniaturized devices [10] [11] [12]. Some applications of
microfluidics include gene chips, labs on a chip, chemical sensors, flow controllers, micronozzles,
and microvalves. In the United States alone, the field of microfluidics has grown to be a $4.45
billion market [13].

Most microfluidic devices consist of 3 layers: the base forms the foundation of the
microfluidic device, a middle layer that channels the flow of the sample, and a top layer to seal
the microfluidic chamber. In some devices, the function of the middle layer is performed by the
top or the bottom layer. Conventionally, microfluidic devices are built on glass or plastic
substrates and an external imaging device is employed for sample analysis. By building
microfluidic devices on integrated circuits (IC), sample sensing can be performed on chip.

2.1 Problem statement
The fragility, small size, and uneven surface of CMOS makes fabrication of microfluidics
on CMOS more difficult than glass. Interaction of subsystems, aqueous nature of biological
samples, and device yield also pose constrains to the integration of the system. This chapter
describes a low cost, high yield technique for the integration of microfluidics and CMOS.
Techniques to improve performance parameters such as capability to sustain pressure and
methods to produce uniform channel edges are also presented.

4

2.2 Literature review
Conventional microfluidic devices built on glass slides are usually fabricated using a
technique known as soft lithography. In this technique a master mold is created and the
microfluidic device is made out of a polymer known as Poly(dimethylsiloxane) (PDMS). The
polymer has a refractive index of 1.41 and is optically transparent from 240 to 1100 nm; this
makes optical imaging, fluorescence imaging, and coupling with light possible. PDMS is flexible,
conforms to surfaces, and can be released from molds without being damaged. This property of
PDMS greatly simplifies the fabrication process. The flexible nature of the polymer makes it
capable of handling pressure and stress without cracking or breaking. PDMS can also be integrated
with circuits as it is electrically insulating. The polymer is nontoxic, inert, permeable to gas, and
has low permeability to liquid making it compatible with cells and proteins [14]. To fabricate the
device, the polymer is poured over the master and cured to define the channels. The PDMS is
then peeled and adhered to a glass slide.

These conventional fabrication techniques do not scale well for IC fabrication, hence
other techniques such as removal of bulk material [15], surface micromachined channels [16], and
SU-8 devices [17] were developed. In bulk removal technique, the silicon substrate is patterned
using a series of photolithography and etching steps. A silicon dioxide layer is used as an etch
mask and the pattern is defined using a photoresist. The oxide is removed to form the walls of the
microfluidic chambers. Pyrex glass is then bonded to the silicon to seal the chambers. Surface
micromachining can be used to develop channels in a variety of materials. With a polymer, a thin
layer is deposited on the prefabricated IC. A photoresist layer defines the channel dimensions and
another polymer layer is patterned to form the walls of the microfluidic chambers. The
photoresist layer is then sacrificed. SU-8 is a photodefinable photoresist; to create microchannels,

5

a thin layer is coated on the surface and developed. This forms the walls of the channels and the
top layer is formed by bonding. These devices are mechanically reliable, and have good chemical
resistance. This technique also provides control over the height of the channel; the thickness of
the SU-8 layer defines the channel height.

Once the microfluidic device is developed, it has to be bonded to a surface; in this case,
complementary metal-oxide-semiconductor (CMOS). Existing bonding techniques can be
classified as direct or indirect. Anodic bonding and fusion bonding are direct bonding techniques.
Anodic bonding requires the surfaces to be cleaned extensively and employs high voltage and high
temperature to form an irreversible bond. Fusion bonding works by application of extensive
pressure after cleaning in vacuum. The substrate is then exposed to heat to form a stronger bond.
Adhesive bonding, eutectic bonding, solder bonding, and thermocompression bonding are types
of intermediate layer bonding. Epoxy, spin-on-glass, or UV curable glue is spin coated on the
surface during adhesive bonding. In eutectic bonding, a thin gold layer is placed between the
silicon layers and heated to gold-silicon eutectic point to form an irreversible bond.
Thermocompression and solder bonding have soft metal layers between the substrates. Pressure
or heat is applied to bond the layers together [18]. Other groups have used these techniques, and
their variations to integrate microfluidics and ICs to develop cell growth tracker [19], impedance
sensors [20], cytometry [21], and capacitive sensor [22].

These microfluidic fabrication and bonding techniques are optimized to develop
microfluidic devices on ICs, but require sophisticated machines and techniques. This affects the
cost of the final system and skill required to develop these sensors. Instead of fabricating the
microfluidic device directly on CMOS, some groups have fabricated the devices on a glass slide or
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a cover slip and placed it on the CMOS sensor [23] [24]. Although this is an effective technique,
sample-sensor separation is incompatible with lensless fluorescence imaging and many chemical
sensing methods.

2.3 Project outline
This chapter solves the existing problems with CMOS microfluidic fabrication by proposing
heat seal adhesive (HSA) tapes fabrication technique. These tapes will be patterned using a laser
cutter, fabricated on CMOS, and sealed with a slab of PDMS. After fabrication on CMOS, the
performance of HSA device will be quantified by measuring the pressure, edge uniformity, and
surface roughness of the fabricated microfluidic device. Due to the delicate nature of CMOS,
quantitative studies will be performed on glass fabricated microfluidic devices and then optimized
to test CMOS fabricated devices. The performance of HSA devices will also be compared to other
devices.

2.4 Methods
This section outlines the fabrication protocol for developing microfluidic devices on a
glass slide and CMOS sensor. Protocols for fabricating HSA, PSA, and PDMS devices are presented
in detail in this section.

2.4.1 Fabrication of HSA microfluidic device on a glass substrate
HSA tapes are made up of a polyester layer coated with heat activated adhesive on both
sides. These tapes are flexible, translucent, and adhere well to surface such as glass, CMOS, and
PDMS. The tapes were purchased from Adhesive research (ARcare 92848) and the schematic of
the tape is shown in Figure 1.
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Figure 1

Anatomy of the heat seal adhesive tape [25]

The design of the microfluidic device was drawn in AutoCAD and the tape was patterned
using a CO2 laser (Epilog Zing – Model 10000). After cutting, the tape was cleaned by sonication;
it was placed in 15% isopropanol for 5 minutes, and in DI water for 5 minutes. The tape was dried
using pressurized air and incubated overnight. To reduce the hydrophobicity induced by laser
patterning [26], the tape was treated with the UV-ozone cleaning system the next day. Uncured
PDMS mixed at 5:1 (v/v) base:curing agent was poured in a dish with a flat base and cured. A slab
of PDMS was cut to dimension to make the top layer of the microfluidic device. The slab was then
punched with a blunt needle to form ports. Two techniques were tested to bond the tape to the
glass slide; direct and indirect adhesive activation. During direct activation, the tapes were laid on
the glass slide and placed on a hot plate for 5 seconds. During indirect activation, the tape was
placed under a hot air gun for 5 seconds to activate the adhesive and was then laid on the glass
slide. Experiments showed no significant difference between the two techniques. After the tape
was laid, a punched PDMS slab was placed on top and held down for two seconds. The device was
then allowed to cool for a minute.
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During the study, it was observed that HSA devices performed well for most imaging
applications, but for applications that require high speed imaging or high pressure, the seal
strength was not consistently adequate. To overcome this potential pitfall, the HSA devices were
reinforced with PDMS. These HSA+PDMS devices demonstrated superior performance when
compared to PSA, PDMS, and HSA devices. To fabricate these devices, adhesive on the patterned
tapes were activated and laid on the glass substrate. A slab of punched PDMS was placed on top
and allowed to cool. Uncured PDMS was then loaded in a syringe and dispensed around the PDMS
slab. The slide was placed under a hot air gun for 2 seconds to cure the thin layer of uncured
PDMS. Once cured, the PDMS on the edge acted as reinforcements forming a reliable tight seal.
Figure 2 shows the fabricated devices.

Figure 2

HSA microfluidic device fabricated on a glass substrate (A) HSA device (B)
HSA+PDMS device

2.4.2 Fabrication of HSA microfluidic device on CMOS sensor
The protocol to pattern and clean glass based microfluidic devices were followed for
CMOS based devices. The cleaned tapes were placed on a punched PDMS slab cut to dimensions.
The slab and the tape were placed under a hot air gun for 5 seconds to activate the adhesive. The
slab with the tape was then placed directly on the CMOS sensor. The device was held in place for
3 seconds before it was allowed to cool. The adhesive was heat activated before it was placed on
the CMOS to prevent sensor damage due to heat and to evenly activate the adhesive. If the
9

adhesive was activated after placing the tape and PDMS on the CMOS, the heat did not transfer
uniformly to the tape through the layer of PDMS.

To make HSA+PDMS devices, an insulin syringe loaded with uncured PDMS was
employed. After the device was allowed to cool, small amounts of PDMS was dispensed around
the device on the surface of the sensor. The sensor was exposed to a hot air gun for two seconds
to cure the PDMS. The fabricated devices are shown in Figure 3.

Figure 3

HSA microfluidic device fabricated on a bare CMOS sensor (A) HSA device (B)
HSA+PDMS device

2.4.3 Fabrication of PSA and PDMS microfluidic devices
To compare the performance of the HSA devices with other devices, PSA and PDMS
devices were developed. PSA tapes are very similar to HSA tapes with a polyester layer and
adhesive. Unlike HSA, the adhesive on these tapes need pressure to be activated. Other groups
have used PSA fabrication to make devices on glass, plastic, and paper [26] [27] [28]. PSA devices
were selected for comparison due to its similarity to HSA and ease of fabrication. Due to the wide
use of PDMS for fabricating microfluidic devices, PDMS devices were also employed for
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comparison. The fabrication technique to develop the devices on glass and the protocol used for
testing is presented in this section.

While designing the devices for glass fabrication, channels with different widths were
designed; the channel width was varied from 0.1mm to 1mm. To make a PSA device on glass, the
tape was patterned and cleaned similar to HSA device fabrication. The protective layers on the
tape were peeled and carefully placed on a glass slide to prevent air bubbles. A slab of PDMS with
punched ports was carefully laid and even pressure was applied to bond the layers together. A
similar protocol was followed to develop the devices on the CMOS sensor. The fabricated devices
are shown in Figure 4.

PDMS devices fabricated in our lab are generally fabricated by etching a copper plate to
create a master. This methods is similar to the toner transfer masking technique presented in
[29]. The surface and edge variation of the PDMS devices made from maters depends on the
surface quality of the master, hence an alternate technique was employed. The design of the
microfluidic device was fabricated on a PCB and used as a master. To make the device, uncured
PDMS was mixed at 5:1 (v/v) base:curing, poured over the master, and allowed to cure overnight.
After the device hardened, it was peeled and punched using a blunt needle to make the input and
output ports. Since PDMS does not possess adhesive properties like the tapes, a modification of
the stamp and stick technique presented in [18] was employed. A thin layer of uncured PDMS
mixed at 5:1 (v/v) base:curing agent was spread on the glass slide. The cured PDMS was placed
on this slide and heated on a hot plate for 30 seconds. The heat cures the thin layer of PDMS and
bonds the device to the glass slide. Fabricated devices are shown in Figure 4.
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Figure 4

PSA and PDMS microfluidic devices (A) PSA device on a glass substrate (B) PDMS

device on a glass substrate (C) PSA device on CMOS (D) PDMS device on CMOS

2.5 Results
This section presents the results from the comparative study of the fabricated devices.
The set up for measuring the performance parameters and the protocol for testing is detailed
below. The measurement set up were tested on glass slide device before they were employed to
test CMOS devices.

2.5.1 Pressure test
Pressure was selected as one of the criteria to compare the devices as it quantifies the
strength of the seal. The device should be strong enough to handle sample flow; due to the small
feature size of the CMOS microfluidic devices, the speed at which the sample is injected and the
pressure applied by the tubing at the ports have a huge effect.

Pressure sensors from omega (PX26-015GV) were purchased and calibrated. For
preliminary data, microfluidic devices fabricated on glass slides were employed. A 22 gauge
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needle (BD PrecisionGlide) was used to punch the ports and #30 size tubing (Cole Parmer PTFE
#30 AWG) was inserted at the ports. The tubing from the input port was attached to an empty
syringe, and the tubing from the output port was attached to the pressure sensor. The electrical
connections for the sensor were made as mentioned in the user manual. Calibration and
measurements were performed at 10 V. Figure 5 shows the pressure measurement set up.

Figure 5

Pressure measurement set-up to quantify the amount of pressure a microfluidic
device can withstand

Data from 8 glass fabricated and 4 CMOS fabricated microfluidic devices were collected
by injecting a gust of air into the devices. The voltage reading on the multimeter connected to the
pressure sensor was recorded. As the air was injected, the pressure inside the device builds up
before a leak is formed. The equivalent pressure corresponding to the highest voltage value was
determined using the calibration graph.
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Figure 6

Pressure test for HSA, PSA, PDMS, and HSA+PDMS devices on a glass slide. The

columns represent the mean pressure and the error bars represent the standard
deviation

Figure 7

Pressure test for HSA, PSA, PDMS, and HSA+PDMS devices on a CMOS sensor.

The columns represent the mean pressure and the error bars represent the standard
deviation

From the data, it can be observed that HSA devices perform better than PSA and PDMS
devices, with HSA+PDMS devices demonstrating much better performance. The performance of
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PSA devices were prone to trapped bubbles between the tape and the glass substrate; devices
with trapped air demonstrated lower performance by a noticeable amount.

2.5.2 Surface roughness
Surface roughness on the materials used for fabrication contribute to height variation.
The height of the channel is critical for optical applications; if the variation is too high, it might
lead to data loss. Hence, to measure the surface roughness, an optical profiler (WYCO NT3300,
Veeco Instruments) was employed. To measure PDMS, the surface of a cured microfluidic device
was measured. For the tapes, the surface variations before and after the activation of the
adhesive did not make a significant difference. The average variation in height on the surface of
HSA, PSA, and PDMS was found to be 3.39 µm, 4.26 µm, and 3.35 µm respectively. Since the
surface roughness for HSA+PDMS devices depends on the surface roughness of HSA tapes, they
were not measured separately. The y axis on the graph represents the height of the material and
the standard deviation represents the surface roughness.

Figure 8

Surface height variation on HSA, PSA, and PDMS. The graph shows the mean
and the standard deviation
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The variation on the PSA and HSA tapes are defined by the properties of the tape, but the
variations on the PDMS depends on the quality of the master used. For applications that require
smoother surfaces, the surface uniformity of the masters must be improved. From the data, it can
be observed that the variations on the surfaces are not very significant, but on a comparative
scale, HSA shows less variation than PSA and matches the performance of PDMS devices.

2.5.3 Edge uniformity
Edge variation is critical in sample flow studies and focusing applications; small variations
in the channel, especially on the edges affect the path of the sample. Edges on a microfluidic
device act as boundaries, restricting the flow of sample. From our experiments, we observed that
the samples flowing close to the edges of the microfluidic device, mimic the variation along the
edges. For applications such as sample flow measurements and sample focusing, the quality of
the edges play a critical role. During the study, it was observed that the settings on the laser
cutter used for pattering the tapes had a huge impact on the quality of the edges. Hence, a range
of settings were used for pattering, before picking the ideal settings. The settings on the laser that
were modified were power, speed, and number of runs. The power determines the amount of
energy the laser uses while making the cut and the speed defines the amount of time the laser
spends on one spot. The user manual mentions that making multiple runs with lower settings
would make a smoother cut than making one run at high power. The optimum speed and power
depends on the properties of material, thickness of the material, and the channel width. We
observed that narrower channels required more runs and different settings to make smoother
edges. The settings that provided the best edge for PSA and HSA tapes are shown in Table 1.
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Device
PSA
Channel width: 0.1-0.4mm
PSA
Channel width: 0.4mm-1mm
HSA
Channel width: 0.1-0.4mm
HSA
Channel width: 0.4mm-1mm

Speed
100%

Power
1%

Number of runs
5

1%

1%

3

100%

100%

5

100%

100%

2

Table 1 Speed, power, and run settings on the laser cutter used in pattering the tape for
microfluidic fabrication

For devices fabricated on glass slides, images of the edges at different sections on the
microfluidic device were captured using a microscope. These images were then analyzed in
Matlab to determine the variation. The algorithm used for measuring edge variation is illustrated
in Figure 9. The original image was read by the Matlab code and converts the image to gray scale.
A canny filter was applied to the image to obtain the edge information. The image was then
dilated to connect the discrete points. Boundary conditions were applied on these regions to
retain the edge information for analysis; retained boundary are marked as upper and lower
boundary lines. A function was then used to fill gaps in the retained edge; the function draws a
straight line between discontinuous regions. After a continuous edge was retained, line of best fit
was drawn and the root mean square error was calculated.
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Figure 9

Stages in the Matab code for quantifying edge variation. (A) Original image (B)

Image after edge detection (C) Identifying boundaries (D) Boundary with best fit line

During fabrication, it was observed that channels made of PSA showed high variations.
This was due to the pressure applied during sealing the device; when pressure was applied, the
adhesive on the edges was forced into the channels causing uneven edges with sharp transitions.
Cleaning a PSA device was also challenging as the adhesive trapped small dust particles and debris.
Quantification of the variation using the matlab code supported our hypothesis; PSA devices
showed maximum variation along the edges. Performance of HSA devices is comparable to PDMS
devices. The root mean square error of the variation along the edges is summarized in 19Figure
10 and Figure 11. Since the edges of the HSA+PDMS devices are formed by HSA tapes, those
devices were not measured.
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Figure 10

Edge variations in glass fabricated devices

Figure 11

Edge variations in CMOS fabricated devices

The graphs show that CMOS fabricated devices show more variations in comparison with
glass fabricated devices. This is due to the uneven surface of the CMOS sensor; minor variations
induced by the surface also contribute to the variations measured by the code. Among the three
devices, HSA showed the lowest variations both on glass and CMOS substrates.
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2.6 Conclusions
HSA fabricated devices show improved performance while reducing cost and fabrication
time. Fabrication of microfluidic devices using HSA tapes and reinforced HSA+PDMS devices
would offer better results in applications such as hydrodynamic focusing, flow cytometry, pinched
flow fractionalization, micro total analysis systems, and hydrodynamic rectification. The inert
chemical properties of the tape makes it ideal for sample delivery and handling in chemical,
biological, and environmental sensors.
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CHAPTER 3
ON-SENSOR FLUORESCENCE IMAGING DEVICE FOR SCREENING BLOOD

Blood performs many important tasks such as transportation of oxygen to organs,
attacking foreign cells, protecting the body from infection by generating antibodies, and
regulating the body temperature to name a few [30]. Blood also contains a lot of information
about the individual’s health; a complete blood count (CBC) is the most common test performed
at hospitals. While performing a CBC, the cell count, morphology, inclusions, cell size, and cell
shape of blood cells are studied. Changes in these properties are associated with various disease
such as infections, bleeding and clotting disorders, and anemia to name a few. There are other
specific blood tests that can screen an array of disease such as hemophilia, diabetes, cancers,
leukemia, lymphoma, myeloma, Ebola, HIV, and hepatitis. Blood is also studied for health
monitoring as it sheds light on cholesterol levels, liver function, kidney function, oxygen levels,
toxicity levels, and other important markers for general health [31]. The recognition of blood as a
corner stone to diagnosis led to the development of many specialized medical instruments.

To optically analyze blood, the cells have to be stained; cells are transparent and need
stains to improve contrast during imaging. Normal stains are used to merely highlight sections of
the cells, such as the nuclei, cell membrane, and mitochondria. Fluorescent stains are more
specific and sensitive than normal stains; they stain the components within the cell by chemically
binding to the target. They also provide better contrast during imaging due to the presence of
fluorescent nanoparticles. These nanoparticles are known as fluorophores; they absorb light at a
specific wavelength and emit light of a longer wavelength. This phenomenon was first observed
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in 1852 by Sir Gabriel Stokes and numerous dyes are commercially available to stain various
proteins present in cells [32].

Fluorescence imaging has proved to be a useful clinical tool, leading to the development
of imaging equipment such as fluorescence microscopes and flow cytometers. These equipment
screen a range of diseases including blood related disorders, cancers, and AIDS. Microscopes have
been an indispensable equipment in diagnosis by providing both qualitative and quantitative
information about the sample. The downside of microscopes is manual screening; the reliability
of this method depends on the experience of the clinician or the pathologist. Flow cytometers are
automated devices that also provide quantitative and qualitative information, making them the
state-of-the-art technique to screen for human immunodeficiency virus (HIV). The drawback of
these devices is the costs associated with the device; commercial flow cytometers cost $35,000
or more and have a maintenance costs of $6000 per year [33]. The other drawback of this device
is clogging; analysis is performed only on one cell at a time, hence the size of the aperture must
be small. The device can handle cells up to 100 µm, which is wider than most cells. The problem
arises when two or more cells are lumped together or when an abnormal cell is being analyzed.
Cancer cells and other unhealthy cells usually tend to be larger than healthy cells, clogging the
system during analysis.

3.1 Problem statement
The cost, fragility, and maintenance of existing fluorescence imaging devices limits their
use to central laboratories. This chapter demonstrates that lensless fluorescence imaging can also
offer qualitative and quantitative information about the sample. Capability of the device to
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analyze more than one sample at a time and techniques to improve throughput is also presented
in this study.

3.2 Literature review
To analyze sample with a flow cytometer, the sample must be stained with fluorescent
dyes using direct labeling or indirect labeling methods [34]. Once stained, it is placed in the device
for analysis. The device employs hydrodynamic focusing to channel the cells into a thin steam.
The cells are then exposed to a laser, one cell at a time, causing the stained sample to emit
fluorescence. This emission is recorded using photomultiplier tubes and photodiodes. The device
records the front, back, and side scatter from the sample. Using all this information, the flow
cytometer can provide cell count, classify cell types, and chemical expression without having to
study the morphology of the cells [35].

To overcome the drawbacks of conventional flow cytometers, some groups have
proposed techniques to miniaturize the device; currently there are two approaches. The first
approach employs the same working principle of flow cytometer by focusing the sample into a
single file. Instead of using the conventional set-up, the functionality is implemented on a
microfluidic chip [36] [37]. This technique still needs an external imaging device such as a
fluorescence microscope to perform sample analysis. The second approach employs an array of
sensing elements to perform lensless imaging. In this approach, the sample is allowed to flow
laterally, increasing cell analysis rate. This technique has been used to analyze sample using white
light imaging, where the shadow of the sample is studied to provide information such as sample
count [38] and movement [39]. The limitation of these techniques is their inability to perform
fluorescence imaging. The specificity and advantages that fluorescence imaging has to be offer
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cannot be exploited by these devices. This drawback reduces the clinical significance of these
miniaturized devices. Existing miniaturized imaging systems that perform lensless fluorescence
imaging employ techniques such as total internal reflection [40], time-domain excitation
separation using high speed pixels [41], spin coated filters [42], and fiber optic phase plate with
fixed sample-sensor separation [43].

In lensless imaging, the sample is directly placed on the imager to collect optical
information. If the object is small and close enough, then lenses are not required to focus the
image on the sensor. This is the principle behind lensless imaging. This type of imaging has been
possible only in the recent past, due to reduction in CMOS feature size. The lack of lenses, reduces
the effective imaging area to a few millimeters above the imager, making this technique ideal for
biological samples. A representation of lensless imaging is shown in Figure 12, the checked pattern
represent the pixels and the red disks represent red blood cells. Figure 13 shows how the signal
to noise ratio decreases as the sample-sensor separation increases during fluorescence imaging.

Figure 12

Illustration of lensless imaging [44]
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Figure 13

Effect of sample sensor separation on lensless fluorescence imaging

3.3 Project outline
The drawbacks of exiting imaging devices can be overcome by developing a lensless
imaging device capable of fluorescence imaging. The proposed device consists of an imager and a
single light source. To offer high throughput, the setup will be designed to analyze flowing sample
with varying sample-sensor separations. A calibration graph will be generated to quantify the
variation in signal strength due to height. The capability of the device to track the sample
movement will also be presented. The performance of the device with fluorescence beads and
cells stained with fluorescent dye will also be demonstrated.

3.4 Methods
CMOS imager from a Logitech (QuickCam Communicate MP S5500) webcam was
employed to demonstrate lensless imaging. The imager was water proofed before exposing the
surface to biological samples. Generation of a calibration graph is critical to deliver reliable data
while quantifying signal strength as it accounts for the signal reduction due to sample sensor
separation. This section details the generation of the calibration graph and the set up to perform
lensless imaging.
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3.4.1 Device calibration
Calibration is achieved in two steps. In the first step, the sample was suspended at random
but fixed heights. In the next step, the width of the fluorescence signal and the height of the
sample was measured. This was performed multiple times to populate the graph shown below.
After the calibration graph was generated, it was used as a reference to quantify the signal
strength during imaging.

Figure 14

Calibration graph that relates the signal strength and the height of the sample
[45]

3.4.2 Lensless fluorescence imaging
There are three main steps involved in developing a lensless imaging system: imager
preparation, microfluidic fabrication, and validation. To prepare the imager, the casing and the
protective glass were removed to expose the bare CMOS imager. To avoid exposing the circuits
to biological sample, superglue was dispensed on the bond wires to waterproof them. The imager
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was left undisturbed overnight before fabricating the microfluidic device. A pressure sensitive
tape (PSA) fabrication technique was employed for initial experiments; after the advantages of
HSA devices were quantified, HSA microfluidic devices were then employed. Microfluidic
fabrication techniques mentioned in the previous chapter was employed to develop PSA devices
on CMOS. The fabricated device used for this study is shown in Figure 15.

Figure 15

PSA microfluidic device fabricated on a bare CMOS sensor for lensless imaging
[46]

The capability of this system was validated by imaging two types of samples: fluorescence
beads and cells stained with fluorescent dyes. Considering the fragility of live cells, the imaging
device was first tested with commercially available fluorescent beads (Spherotech FP-10045-2);
these beads are used to calibrate clinical flow cytometers. During imaging, 1 µL of the original
solution was mixed with 500 µL of DI water to make the working solution. To prepare biological
sample stained with fluorescence dyes, RAW 264.7 cells from ATCC were grown on fibronectin
treated glass slides and incubated overnight. Quantum dots from Invitrogen (Q25011MP) were
mixed and incubated with the cells for 3 hours. Once the cells were stained, they were detached
using trypsin and centrifuged. The cells were then harvested and mixed in PBS.
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The imaging setup consisted of a CMOS fabricated microfluidic device, syringe pump, and
a UV source; the complete set up is shown in Figure 16. Tubing with a diameter of 1mm was
inserted at the input and output ports to carry the sample. Due to the flexible nature of PDMS,
the polymer automatically forms a tight seal around the tubing. Tubing from one port was
connected to a syringe pump containing the sample. Tubing from other end of the microfluidic
device was attached to a microcentrifuge tube to collect the imaged sample. During white light
imaging, the environmental light was used to illuminate the sample and the shadow casted by the
sample was recorded for analysis. For fluorescence imaging, the sample was excited with a UV
source. For this experiment, a hand held UV source was employed. A video of the sample flowing
through the device was recorded and the frames were analyzed in Matlab.

Figure 16

Imaging set up to perform lensless imaging [46]

After the video of the sample flowing through the microfluidic device has been recorded,
the Matlab code splits the video into individual frames. To improve processing speed and save
space, one in every five frames are analyzed. The following image processing is performed on each
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frame to detect the beads in the frames. A threshold function is applied to the first frame to retain
the beads and remove the background. The pixel location of the center of the retained beads is
saved in a matrix. A small bounding box is drawn around the retained point to include the bead.
A 2D gaussian fit is performed to measure the diameter of the fluorescence emission. This data is
collected from all retained frames. To track the sample across frames, boundary conditions are
set in Matlab based on the sample injection speed. The pixel values of the center of the bead
from frame ‘n’ is used to define a bounding box for frame ‘n+1’. The location of the bead inside
the bounding box is saved. The bounding box is used to find the location of the beads from the
input port to the output port.

3.5 Results
During imaging, sample was injected into the PSA device at the rate of 5 µL/min. to
perform UV imaging, the sample was excited with a UV source and Consecutive frames of the
video captured by Matlab while the sample was allowed to flow is shown in Figure 17.

Figure 17

Consecutive frames of sample flowing inside a PSA microfluidic device. (A-C)
fluorescent beads (D-F) cells stained with fluorescent dyes [45]
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3.5.1 Results with flow applications
Imaging techniques such as streak imaging and particle image velocimetry provide
information on sample flow but offer poor height resolution. These techniques also require an
elaborate imaging set up for recording the sample. By employing the proposed imaging setup,
sample movement can be determined by recording a video of the sample flowing on the imager.
Matlab code can detect and track the movement of sample across frames. In the example shown
below, the code tracks the movement of a fluorescent beads inside a HSA microfluidic device. The
solid black lines represent the walls of the microfluidic device and the dashed black lines are the
input and output ports.

Figure 18

Sample tracking using lensless fluorescence imaging device and HSA microfluidic
device

3.6 Conclusions
The capability of the proposed imaging device to perform fluorescence imaging creates
numerous clinical applications. The ability to offer both quantitative and qualitative information
has diagnostic significance as it can be used to classify cell types. Fluorescence dyes used to stain
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the cells offers specificity required to detect organisms such as virus and proteins present in the
sample.
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CHAPTER 4
SINGLE USE LOW COST ASSAY FOR HEPATITIS C SCREENING

Hepatitis C is a disease that affects the liver; this disease is caused by the hepatitis C virus
(HCV) and it primarily spreads by blood-to-blood contact. The symptoms of the disease are hardly
noticeable and infected individuals can live up to years completely unaware of the infection. Over
time the disease causes liver damage, liver tissue scaring, liver cancer, and eventually results in
death [47]. In the US about 3.7 million individuals are infected and 2.8 million (75%) are
undiagnosed; globally, the total number infected is about 170 million [48]. The complexity in
handling this disease has many dimensions; some of the issues are discussed here.

There are currently no vaccinations available for HCV, and the success of treatment
depends on how early the disease is diagnosed [49]. Due to the way in which the disease manifests
itself, the presence of the virus is detected usually after the disease has progressed. This has a
huge impact on the treatment costs and recovery [50]. The other factor contributing to the high
undiagnosed percentage is the high risk population for this disease; this population mainly
consists of injection drug users, prisoners, and individuals at homeless shelters. A huge fraction
of the infected population, especially the high risk population suffer from serious economic
problems preventing them from getting themselves tested for HCV. More than 75% of the
infected population are baby boomers; people born during 1945-1965. The reason for this is due
to the high prevalence of HCV infection during that period. HCV was identified only in 1988 and
tests were developed only in 1992. Blood transfusions, organ transplantation, and lack of
awareness about this disease before this period contributed to the steady increase in the number
of infected cases [51]. The percentage of the infected population who are unaware of their
infection, continue to spread the disease making this a growing problem [52].
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At hospitals and clinics, screening is conducted by performing two tests: serologic assay
and molecular assay. The serologic assay, looks for the presence of HCV antibody in the blood
serum collected from the individual. This indicates that the individual’s immune system is actively
fighting the virus. The molecular assay, looks for the presence of virus in blood; this test is more
sensitive and provides more information on the disease. The results of both tests are critical for
proper diagnosis [53], but taking cost and convenience into account, the centers for disease
control and prevention (CDC) recommends the serologic assay as the primary test [54].

To screen the high risk population, it is critical to be able to perform screening in the field.
There are currently two approaches to field screening: sample collection for conventional
screening and rapid testing. In the first approach, a phlebotomist collects blood sample for the
serologic assay, and sends the sample to the hospital or clinic. With the result from this test, the
phlebotomist makes another visit to discuss the results and collect blood sample for the molecular
assay. The sample is then sent to the hospital and with the results, the phlebotomist makes a final
visit to discuss the complete results. With every visit the phlebotomists makes, following up with
individuals becomes tougher, especially among the high risk population consisting of homeless
people. The other problem is the turnaround time and cost; including transportation, this
approach has higher associated costs than screening at hospitals. The second field testing
approach is to employ a rapid test; these tests are commercially available HCV screening device
that can be used in the field, produce results within half hour, and costs less than conventional
screening. The downside of these rapid tests is its ability to perform only the serologic assay. The
serologic assay can detect the presence of the disease, with exceptions; if the infection was
acquired in the past six months or if the individual has a compromised immune system, this test
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will not be able to detect the presence of the disease [54]. Immunosuppression is common among
individuals infected with HIV and immune system disorders. According to CDC, 25% of this
population (0.3 million) is co-infected with HCV; this number represents only a fraction of
population that the serologic assay cannot detect [55].

4.1 Problem statement
Lack of resources, accessibility issues, and disease manifestation have been the main
obstacles in reducing the number of undiagnosed individuals. A low cost, high speed, field test
capable of performing complete screening by detecting antibodies, detecting the presence of
virus, and classifying the virus subtype would be an ideal solution to the existing problems. This
chapter demonstrates the techniques that can be used to develop a complete rapid test for
hepatitis C.

4.2 Literature review
Enzyme-Linked ImmunoSorbent Assay (ELISA) and immunoblot tests are commonly
performed for serologic testing at hospitals. ELISA requires a pretreated cell culture plate that has
affinity toward the antibodies being screened. The antibody-antigen binding induces a
colorimetric reaction, and the change in color is detected using the plate reader. Optical plate
readers are equipped with monochromators, diodes, detectors, and optics to quantify the
outcome of the test. Field devices such as the OraQuick HCV rapid test performs serologic assays
using similar binding techniques for detection. Unlike ELISA, this test uses indirect lateral flow
immunoassays [56]. A list of rapid tests that can perform serologic assay is presented in Shivkumar
et.al. [52].
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Molecular testing provides quantitative results by detecting the amount of virus present
in blood. It also provides information on genotyping; HCV can be classified into at least 6 major
sub types. The subtype information is critical in deciding the treatment plan for the individual
[53]. Manual or semi-automated reverse transcriptase polymerase chain reaction (RT-PCR) is used
for performing this test. All cells, including viruses have a nucleus with Deoxyribonucleic acid
(DNA); the DNA contains the genetic information of the virus. Molecular assays detect the
presence of the virus by identifying this genetic information. The concentration of the virus in
blood is as low as 10-50 IU/ml, hence the amount of virus has to be amplified for detection. The
RT-PCR achieves amplification by binding primers to generate copies of the original DNA sequence
[57].

Tang et.al have developed a HCV screening device that can not only perform serologic
assay by detecting the presence of HCV antibody in blood, but can also classify the subtypes of
the virus. The proposed device is an immunosensor array that simultaneously detects the
antibodies within 5 minutes. Although the chemistry for the test is carried out on the sensor, an
electrochemical analyzer is required for performing the voltammetry analysis limiting the use of
this sensor to a laboratory setting [58].

Electrochemical measurements for biosensing can be performed using many techniques
such as square wave, cyclic, differential pulse measurements, and electrochemical impedance
spectroscopy (EIS). Among them, EIS has the lowest detection limit and can be used to detect
various biomolecules [59] [60]. EIS is a label free biomolecule detection technique that measures
the changes in impedance for detection. This technique employs electrodes functionalized with
molecules that have affinity for the target molecules. As the binding occurs, the changes in surface
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impedance is measured. With this technique, it is possible to monitor the changes in real time. In
spite of these advantages, the challenges associated with EIS such as bulky instrumentation and
expensive bench-top systems, limit the use of this technique. Some groups have developed fully
integrated biosensors on CMOS [60] that can perform EIS, but the costs associated with
fabrication increases the cost of the device. To reduce the cost and for ease of fabrication, other
groups have miniaturized the sensor by fabricating the electrodes on a printed circuit board [59]
[61]. The downside of these systems is the need for a lab based electrochemical equipment to
conduct the test.

4.3 Project outline
The requirements for developing a screening device for this work will be derived from a
human factor study conducted to observe conventional field testing practices. Observations and
findings from the study will be used as inputs during system integration to make the device user
friendly.

To demonstrate feasibility of the screening device, a prototype that can detect the
presence of biological sample will be developed. A PCB consisting of electronics to perform EIS
will conduct the tests and the data will be sent to a computer via USB cable. A Matlab code will
analyze the data and display the outcomes of the test. A microfluidic device on the printed circuit
board will channel the sample to the functionalized gold electrodes where the electrochemical
reaction will occur. This chapter will discuss the following aspects of the proposed system: findings
from the human factor study, design of the electrodes, protocols to functionalize the electrodes,
PCB design, microfluidic fabrication, microcontroller and Matlab code, and results from the
device.
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4.4 Methods
Serologic assays are capable of detecting the antibody and the virus in the sample. Before
PCRs were widely available, serotyping was performed for antibody and virus detection. A study
comparing serotyping techniques with genotyping techniques show a high correlation of 94%
[62]. The main drawback of conventional serologic assay is the detection; colorimetric readout
requires an optical readout machine that detects the enzyme activity in the assay. This work
borrows the chemistry from ELISA based testing and uses electronic detection instead of optical
detection.

The working principle of the device is binding the target molecule from the solution to
the functionalized electrodes on the PCB. This binding will be proportional to the change in the
impedance of the electrodes. By measuring the impedance, quantitative information on the
target molecule can be obtained. By functionalizing the electrodes with different proteins, tests
for HCV antibody and the virus can be designed.

4.4.1. Human factor study
Commercially available HCV rapid screening tests, OraQuick was employed during the
human factor study [56]. This device can perform the antibody tests and produce results within
20-40 minutes. The motive behind this study was to observe the steps involved in screening, time
taken to perform these steps, and determine the familiarity of technology among subjects. The
observations were then used as an input to design the screening device. The study was performed
at two performance sites: Hampshire county jail, and at a Samaritan inn in Westfield, MA. A
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protocol for the human factor study was submitted to the IRB and approved before the study was
performed. A CLIA waiver was also obtained for using OraQuick HCV for screening purposes.

Mobile screening of HCV has certain procedures and policies that has to be followed; the
complete list is detailed in Zucker et.al [63]. The individuals being screened are required to fill out
a risk factor assessment form and past medical history assessment form as a part of routine
screening. Before screening, the purpose of the human factor study was explained to individuals
and if they were willing to take part, they were asked to sign the consent form and fill out the
technology questionnaire. To make the data collection anonymous, a barcode was associated
with every subject. The barcode was place on every page of the paper work. Before collecting the
blood sample from a finger prick, the finger was sanitized with an alcohol wipe. The first drop of
blood was discarded and the next drop was collected using a scoop. The blood was then mixed
with the buffer and the test device was inserted into the buffer. A timer was set for twenty
minutes to indicate when to check the results.

While screening at the Hampshire county jail, the HCV screening booth was one among
15 booths set up in the facility. Inmates had about 20-30 minutes to visit any booth in the camp.
To save time, they were asked to fill out the paper work the night before the screening. At the
booth, the subjects read and signed the consent forms before being screened. They were given
basic counselling about the disease and on how they can reduce the risk of acquiring the disease.
Data from a total of 28 subjects were collected from both sites. The graph shown below illustrates
the average time taken each step. The steps mentioned in the graph correspond to the following.
Step1: Time taken to fill out all paper work including medical history, risk assessment, consent
form, and the technology questionnaire
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Step2: Setup time including time taken to prepare the kit for sample collection and collecting
blood sample
Step3: Counselling after sample collection

Figure 19

Data collected from the human factor study. Columns represent the mean and
error bars represent standard deviation for each step in screening [64]

The standard deviation is large because of the following reasons: at the prison, since the
inmates were asked to fill out paper work the night before screening, data for step 1 was collected
by asking them how long the paper work took. At the Samaritan inn, there were no time
constraints and the subjects spent more time in step 1 and step 3.

The technology survey asked the subjects to answer the following questions: if they have
used smart phones, do they use text messaging services, if they have an email account. From the
data collected, 20 out of 28 have used smart phones in the past three years, 19 out of 28 use text
messages, and 21 out of 28 have email accounts. Only 5 out of the 28 answered no to all three
questions.
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Based on the observations and conversation with the personal involved in screening,
some key observations were made. An average of 70% of the total screening time is spent in paper
work. Familiarity with technology among the focus group can be used to our benefit to replace
paper work; all forms and personal information can be collected electronically.

Most of the time spent on step 2 were to set up the kit for sample collection; the kit
contains a loop for sample collection, a container for the buffer, a stand to hold the container,
and the test device itself. They are individually wrapped and have to be opened right before using
them to reduce chances of contamination. With the time constraint at the county jail, two trained
personnel was required to set up and collect samples respectively. A system that has a simple
user interface would reduce the time spent in this step.

Since the results of the rapid test employed in this study had to be read out manually, a
nurse had to set a timer, match the barcodes with the sample containers, and manually record
the results for each subject.

Counselling is a critical step in screening, as it educates the individuals about the disease.
Apart from individual counselling, email, text messages, and other technology aided modes can
be employed to make this more effective. Technology could also help with following up with
individuals and providing them information regarding screening centers and health camps.

From these findings, the following inputs for the proposed system were identified. The
device has to possess a simple interface to expose the blood sample to the electrodes. The
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screening must be affordable and take less than 10 minutes. Screening must be completely
automated and reliable.

4.4.2. Electrode design
Many different geometries and materials have been studied for electrochemical
measurements. Conventional measurements employ 3-electrode systems consisting of a working,
reference, and counter electrodes made of gold, platinum, silver, or silver chloride. For our
measurements, we employed gold interdigitated electrode due to its increased sensitivity and
signal to noise ratio [65]. Interdigitated electrodes have also led to the use of two-electrode
systems. Min et.al compared the performance of gold and platinum by studying the signal-tonoise ratio, and overall signal magnitude and concluded that gold had a superior performance
[66]. Coating gold on copper wires using electroless techniques is an established protocol in PCB
manufacturing [67]. Figure 20 shows the electrode pattern used for this device. The width and
the spacing for the electrodes were chosen to optimize the electric field above the electrodes
during measurements [68]. The width of the fingers and the spacing between the fingers were
designed to be 0.15 mm on both topologies. The small electrodes were designed to be 3 mm x 3
mm and the large electrodes were designed to be 6 mm x 6 mm.

Figure 20

Interdigitated electrodes (A) PCB design (B) Fabricated electrodes
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4.4.3. Functionalization protocol
In order to perform EIS, the electrodes must be functionalized to perform affinity-based
sensing. To prove that the proposed device can be used for screening, detection of +36 green
fluorescence protein (GFP) [69] [70] was demonstrated with this device. To detect the protein, it
has to bind to the surface of the electrode; since the protein does not have affinity toward gold,
a thiol group was used to induce binding. The illustration of protein binding to the gold is shown
in Figure 21.

Figure 21

Illustration of gold electrodes with self-assembled monolayer and green
fluorescent protein

To form a thiol group on the gold, a self-assembled monolayer (SAM) of 3Mercaptopropionic acid (3-MPA) and 11-Mercaptoundecanoic acid (11-MUA) was formed. For
this study, a 10mM of 3-MPA and 11-MUA were prepared in absolute ethanol. The gold electrodes
were cleaned and immersed in 3-MPA and 11-MUA mixed at a 10:1 ratio. After 20 hours of
incubation in room temperature, the electrodes were rinsed in ethanol and DI water. A working
solution of 3µM of the +36 GFP in Phosphate-buffered saline (PBS) was prepared and exposed to
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the electrodes for 30 minutes. The electrodes were then washed with PBS to remove unbound
protein.

A mixture of thiol groups with different lengths was selected as it demonstrated better
surface coverage compared to homogenous thiol groups [71]. During incubation, the thiol group
self assembles on the gold surface forming a uniform monolayer; the SH group binds to the gold
exposing the carboxyl group. When exposed to the GFP, the protein binds to the exposed carboxyl
group.

4.4.4. PCB design
The printed circuit board houses the electrodes, conduct the test, collects the data, and
sends it to a computer for analysis. To perform EIS, the electrodes must be fed with a sine wave
and swept over a wide range of frequencies. In order to quantify the surface chemistry on the
electrodes, the output and the input signals of the electrodes must be measured and compared.
This section outlines the working principle of the device.

The main components on the board are the waveform generator chip and the
microcontroller. The waveform generator chip (AD5932) from Digikey consists of programmable
registers that define the start frequency, frequency increment, and number of increments. The
registers were programmed to generate a sine wave output of 500 mV from 100 Hz to 10 kHz.
After the registers were written, a pin on the chip had to be pulsed to initiate waveform
generation. The pin was pulsed to increase the frequency; each increment increased the
frequency by 100 Hz. The microcontroller (PIC32MX795F512L) with bootloader was employed in
this study. The PCB was designed with a USB port to facilitate serial communication with the
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computer. The microcontroller was programmed to write the registers, provide supply, and clock
to the waveform generator chip. The generated sine wave was sent to the electrodes; the input
and the output signal of the electrodes are then sent back to the microcontroller. The
microcontroller digitizes the signals with the aid of the 10bit ADC and sends the data to the
computer via serial interface.

Figure 22

Printed circuit board to conduct electrochemical impedance spectroscopy

The components on the electrode PCB form an impedance divider with the resistor on
top and the electrodes in the bottom; the topology is shown in the illustration below. The
amplitude of the output sine wave changes depending on the impedance of the electrodes. From
initial experiments, a resistance value of 1kΩ was found to be optimal. The main board consisting
of the chips and the electrodes board is shown in Figure 23.

44

Figure 23

Topology used for measuring impedance change in electrodes

4.4.5. Microfluidic fabrication

The microfluidic device helps to contain the sample directly on top of the electrodes
during the test. From the human factor study, it was evident that using sample collection loops
and other apparatus increases screening time and effort. Designing a microfluidic device with a
wide open port enables the sample to be directly placed on the board. For this application, a
simple PSA based microfluidic device would suffice. The fabricated device is shown in Figure 24;
blue food color was injected in the microfluidic device to demonstrate functionality. The input
port is where the blood from a finger prick will be placed. The sample automatically flows into the
electrode region directly on top of the electrodes. The narrow channels offers a high resistance
path to the output port; this region ensures that the sample flows into the electrode region and
stays on the electrodes during while EIS is conducted.
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Figure 24

Microfluidic device on PCB for sample containment

4.4.6. Microcontroller and Matlab code

The microcontroller code is loaded on the PIC32 and it runs every time the board is
powered. The Matlab code initiates the data transfer from the microcontroller and logs the data
for every frequency. The Matlab code then calculates the change in impedance, rendering a phase
spectrum, amplitude spectrum, and a Nyquist plot.

When the board is plugged in, the microcontroller code writes the registers in the
waveform generator and waits for a signal from Matlab. The Matlab code opens a serial port and
writes a character. This write indicates that Matlab is ready to receive the data. Once the
microcontroller receives this character, it pulses a pin on the waveform generator and produces
a sine wave of 100 Hz. The input and the output of the electrodes are fed to two analog pins on
the microcontroller. These signals are alternatively digitized and the values are stored in the ADC
buffer. A frequency dependent delay is programmed between consecutive sampling points on
each signal; this ensures that 20 points are samples for every period of the sine wave. A total of
100 sampled points from each signal and 5 characters representing time information is sent to
Matlab. Matlab waits till the buffer contains 210 characters; once the buffer is full, Matlab reads
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the value and saves it in a matrix. The matlab code runs this in a loop for 100 times to collect data
for 100 frequencies (100 Hz to 10 kHz with an increment of 100 Hz).

Once all the data is collected from all frequencies, Matlab analyzes data from one
frequency at a time; the code calculates the amplitude of the signal, phase difference between
the signals, and change in impedance. For instance, 100 data points corresponding to 100 hz is
retrieved from the saved matrix. Using Matlab’s inbuilt data interpolation function, 100 points are
inserted between each exiting data points; this increases the number of points from 100 to 9901;
shown in Figure 25. This increases the resolution of the data, improving the accuracy of amplitude
and phase calculations.

Figure 25

Original data points and interpolated data points

The offset of the signal is determined by calculating the mean of the voltage values. From
the mean, the maximum variation from the mean represents the maxima and minima in each
period. The average of these values gives the amplitude of the signal. The phase difference
between the signals is calculated by measuring the time lag between the maxima points of the
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input and output. To calculate this, all data points are given a precise time stamp; the time
information sent from the microcontroller is used to determine this value. An array that has the
maxima point from each period and the corresponding time stamp information is saved. The
maxima points calculated by the code is marked with a black cross in Figure 26.

Figure 26

Maxima and minima points on input and output signals

The time difference between the maxima points of the signals in each period is saved.
This information is converted to phase difference using the following formula. Phase information
from each period is averaged to calculate the phase difference between the signals.

Phase = 360 ∗ 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 ∗ 𝑇𝑖𝑚𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒

With the phase difference and amplitude information, the impedance of the electrodes
are calculated using the following equations,
𝑅𝑒𝑎𝑙 = 𝑍 ∗ cos 𝜃
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𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦 = 𝑍 ∗ sin 𝜃
Where,
𝑍=

𝑉𝑜𝑢𝑡 ∗ 1000
𝑉𝑖𝑛 − 𝑉𝑜𝑢𝑡

θ = phase difference
4.5 Results
Before integrating the system, the subsystems of the device were tested using traditional
lab equipment to validate their functionality. The performance of the integrated system was
tested by measuring change in impedance with different samples. Amplitude spectrum, phase
spectrum, and Nyquist plots from data collected using the proposed device is presented in this
section.

4.5.1 Saline solution
For preliminary testing, bare gold electrodes were exposed to saline solution of different
concentrations. The change in amplitude and phase spectrum with different concentrations of
sodium chloride was recorded. Three concentrations of 0.1M, 0.5M, and 1M NaCl solutions were
prepared and 20µL of the salt solution was dispensed on the electrodes during the tests.

Theoretically, solutions with high salt content conduct better than salt solutions with low
salt concentrations. Hence, the resistance measured from 0.1M NaCl must be highest and the
resistance of 1M should be the lowest. The Nyquist plot should also show a similar trend; the plot
should shift and increase as the concentration increases. The data shown in Figure 27 agrees with
the hypothesis.
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Figure 27

EIS results from NaCl with different concentrations (A) Amplitude spectrum (B)
Phase spectrum (C) Nyquist plots

To ensure that the system is working with an acceptable accuracy, the data collected from
the device was compared to data from an oscilloscope. The input and output waveforms were
sent to the microcontroller and simultaneously measured using an oscilloscope. The scope
measured the amplitude and phase difference of the signals. The values that Matlab calculated
with the data sent from the microcontroller was compared to the values from the oscilloscope;
data is shown in Figure 28.
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To conduct this experiment, EIS was conducted by dispensing 20µL of 0.1M NaCl on bare
gold electrodes. The output amplitude and phase difference were measured at discrete
frequencies using the scope. The device was then used to run EIS for the complete frequency
range of 100 Hz to 10 kHz.

Figure 28

Plots comparing the values from an oscilloscope and the proposed device (A)
Output voltage (B) Phase difference

From the data, it can be observed that the amplitude and phase difference calculated
with data from the device has a high correlation with the data from the scope. The error in phase
difference could be due to the effects of using wires to measure the sine waves on the board. The
phase value displayed on the scope also displayed a variation of about 3°-5°. This effect increases
as the frequency of sine wave increases.

4.5.2 Protein detection
Protein detection was performed on functionalized gold electrodes. The electrodes were
treated with the thiol group to form SAM on the gold surface. 20µL of DI water was dispensed on
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top of bare gold electrodes and electrodes treated with thiol group to record the change in
contact angle [72]. Figure 29 shows a decrease in the contact angle confirming the formation of
SAM on the gold.

Figure 29

Contact angle on gold surface (A) Bare gold electrodes (B) Gold electrodes after
the formation of SAM

To conduct EIS, 20 µL of PBS was dispensed on gold electrodes treated with SAM. The
data from these electrodes were collected and saved in Matlab. The same set of electrodes were
exposed to GFP, and measured with PBS. Change in values before and after protein binding are
shown in Figure 30. SAM layer on gold should increase the conductivity and reduce the measured
resistance [73]. As expected, the resistance of SAM is much lower compared to salt solution on
bare electrodes. When the protein binds to the SAM, it inhibits conduction leading to an increase
in resistance as shown in Figure 30 (A).
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Figure 30

Protein detection using proposed device (A) Amplitude spectrum (B) Phase
spectrum (C) Nyquist plot

To calculate the error margin, multiple data sets from a single electrode was collected
before and after treating them with the protein. The data was analyzed in Matlab and a graph
with error bars was generated; shown in Figure 31. The impedance difference at low frequencies
(higher x axis values) is distinct before and after binding. As the frequency increases, the error
bars overlap; this could be associated to the phase variations noticed at high frequencies.
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Figure 31

Error margin before and after protein detection

4.5.3 Protein detection with commercial electrodes
When the size of the target molecule decreases, the change in impedance also decreases.
To verify that the proposed system can adapt to detect smaller biological samples, the system
was integrated with commercial electrodes. Interdigitated gold electrodes from Micrux (ED-IDA1Au) were used to detect the same +36 GFP. The electrodes were treated using the same protocol
and the impedance change before and after protein binding is shown in Figure 32.
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Figure 32

Protein detection using proposed device and commercial electrodes

The impedance difference is one order of magnitude higher than the fabricated
electrodes. From this experiment, it is evident that the sensitivity of the system can be improved
by using smaller electrodes. Reducing the size of the electrodes confines the electric field closer
to the surface of the electrodes which in turn improves sensitivity [72].

4.6 Conclusions
The capability of the device to perform EIS can be extended to screen for HCV by
modifying the surface chemistry on the electrodes; this can be achieved by activating the SAM
layer and coating the electrodes with antibody that has affinity for HCV antigen and HCV virus.
Compared to conventional screening methods, this device would be faster, cheaper, and offer
complete screening. The cost of fabricating the electronics PCB and the electrodes PCB was $67.
Since the electrodes are the only part of the device that come in direct contact with the sample,
it can be single use and the electronics board can be reused. This would reduce cost per test to
about $20; mass production would further reduce screening costs.
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The functionality of this device can also be extended to screen for other diseases by
modifying the chemistry. By borrowing the surface chemistry from ELISA kits, the electrodes can
be coated with antibody that has affinity for any target molecules. This exponentially increases
the number of diseases that can be screened simultaneously using the proposed device.
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CHAPTER 5
CONCLUSION

Point of care devices and hand held health monitoring devices have already started to be
a part of lives. We hope that the techniques and systems presented in this thesis help push the
envelope of this field.

The microfluidic fabrication techniques presented here have been validated by
integrating the devices with optical and electrochemical sensors. The proposed fabrication
techniques can be applied to numerous miniaturized sensors and devices for sample handling and
manipulation. The fabrication techniques can also be employed to develop microfluidic devices
with advanced functionalities such as mixing, focusing, and filtering.

The optical and electrochemical systems presented in this thesis not only overcome
drawbacks of existing clinical screening methods, but also has the potential to improve current
state of technology. The ability of the optical system to detect flowing sample could improve
throughput by 100x. This would shed light on sample analysis and open doors to what had been
impossible or laborious in the past. Chemical FETs can be developed on CMOS sensors and
integrated with microfluidic devices to develop a completely new range of sensors. These devices
can offer optical and chemical information about the sample under investigation.

The electrochemical sensor not only offers rapid and low cost screening but has the
potential to revolutionize mass screening. By integrating technologies such as near field
communication (NFC) device, screening can not only be fast, but completely automated and
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secure. In this new model, individuals being screened would fill out their personal details and
medical form on their phone or tablets. At screening booths, the data from their phones would
be transferred to the passive NFC tag on the PCB. Along with the data from the test, the
information from the electronic forms also gets transferred to the computer. An application on
the computer would automatically save the individual’s personal records and the result of the
test. When healthcare providers screen individuals for HCV, they must report a positive case to
the state; the software could do this automatically. The software could also send counselling
information and information about the disease over emails or messages to the individuals.

The functionality and potential of such point of care devices are numerous. The new
generation of miniaturized devices would also help in transforming the traditional model of going
to hospitals for medical care and screening. Early detection of diseases and continuous health
monitoring would pave way for a healthier tomorrow.
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